Literature DB >> 21041274

Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patients.

So-Young Bang1, Tae-Hwan Kim, Bitnara Lee, Eunji Kwon, Sang Hyun Choi, Ki Soo Lee, Seung Cheol Shim, Angela Pope, Proton Rahman, John D Reveille, Robert D Inman.   

Abstract

OBJECTIVE: Investigators from the Australo-Anglo-American Spondyloarthritis Consortium have reported additional genes associated with ankylosing spondylitis (AS) susceptibility including IL1R2, ANTXR2, and gene deserts at 2p15 and 21q22. We evaluated these new candidate genes in a large cohort of Korean patients with AS.
METHODS: A group of 1164 patients with AS and 752 healthy controls were enrolled for our study. Eight single-nucleotide polymorphisms (SNP) were analyzed to define genetic association with AS by MassARRAY system.
RESULTS: Significant positive associations of AS with endoplasmic reticulum aminopeptidase 1 SNP, rs27037 (p = 1.31 × 10(-4)), and rs27434 (p = 4.59 × 10(-6)), were observed. The rs10865331 of gene desert at 2p15 also showed a significant association with AS (p = 4.63 × 10(-5)).
CONCLUSION: This is the first confirmation in a nonwhite population that genetic polymorphisms of rs27037, rs27434, and rs10865331 are associated with AS, implicating common pathogenetic mechanisms in Korean and white patients with AS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041274     DOI: 10.3899/jrheum.100652

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Anthrax toxin receptor 2 gene (ANTXR2) rs4333130 is associated with ankylosing spondylitis.

Authors:  Yanjuan Ou
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Genetics and the Causes of Ankylosing Spondylitis.

Authors:  Aimee Hanson; Matthew A Brown
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 3.  Associations between ERAP1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2016-04-25       Impact factor: 2.980

Review 4.  ERAP1 in the pathogenesis of ankylosing spondylitis.

Authors:  Emma Reeves; Tim Elliott; Edward James; Christopher J Edwards
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

5.  ERAP1 rs30187 single nucleotide polymorphism does not confer disease susceptibility in North Indian children with enthesitis-related arthritis.

Authors:  Rajni Srivastava; Sanat Phatak; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2017-02-04       Impact factor: 2.980

Review 6.  Genetics of spondyloarthritis--beyond the MHC.

Authors:  John D Reveille
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

7.  Association between ERAP1 gene polymorphisms and ankylosing spondylitis susceptibility in Han population.

Authors:  Jian Wang; Hang Li; Jianwei Wang; Xiang Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis.

Authors:  Chin-Man Wang; Huei-Huang Ho; Su-Wei Chang; Yeong-Jian Jan Wu; Jing-Chi Lin; Pi-Yueh Chang; Jianming Wu; Ji-Yih Chen
Journal:  Arthritis Res Ther       Date:  2012-05-25       Impact factor: 5.156

9.  rs10865331 associated with susceptibility and disease severity of ankylosing spondylitis in a Taiwanese population.

Authors:  Ya-Feng Wen; James Cheng-Chung Wei; Yu-Wen Hsu; Hung-Yi Chiou; Henry Sung-Ching Wong; Ruey-Hong Wong; Shiro Ikegawa; Wei-Chiao Chang
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

10.  Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.

Authors:  Liye Chen; Anna Ridley; Ariane Hammitzsch; Mohammad Hussein Al-Mossawi; Helen Bunting; Dimitris Georgiadis; Antoni Chan; Simon Kollnberger; Paul Bowness
Journal:  Ann Rheum Dis       Date:  2015-06-30       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.